Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. (Q54255971)

26 May 2018

title

Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. (English)

1 reference

26 May 2018

1 reference

1 reference

1 reference

1 reference

12

Timothy R Donahue

1 reference

26 May 2018

author name string

James J Farrell

1

1 reference

26 May 2018

Paul Toste

2

1 reference

26 May 2018

Nanping Wu

3

1 reference

26 May 2018

Luyi Li

4

1 reference

26 May 2018

Jonathan Wong

5

1 reference

26 May 2018

Daniel Malkhassian

6

1 reference

26 May 2018

Linh M Tran

7

1 reference

26 May 2018

Xiaoyang Wu

8

1 reference

26 May 2018

Xinmin Li

9

1 reference

26 May 2018

David Dawson

10

1 reference

26 May 2018

Hong Wu

11

1 reference

26 May 2018

language of work or name

English

0 references

publication date

11 June 2013

1 reference

26 May 2018

The American Journal of Gastroenterology

published in

1 reference

26 May 2018

volume

108

1 reference

26 May 2018

issue

8

1 reference

26 May 2018

page(s)

1352-1359

1 reference

26 May 2018

Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA expression pattern in intraductal papillary mucinous neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Integrative survival-based molecular profiling of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.167

1 reference

26 May 2018

1 reference

26 May 2018